The Latin America, Middle East and Africa Softgel Capsules Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 62.2 million units, showcasing a growth of 9.0% (2023-2030).
The softgel capsules market, an integral component of the pharmaceutical and nutraceutical industry, has exhibited remarkable growth in recent years, underpinned by several transformative factors and a constant quest for innovation. Softgel capsules, known for their versatility, enhanced bioavailability, and ease of consumption, have gained significant traction across a wide array of industries, ranging from pharmaceuticals and dietary supplements to cosmetics and food products.
In pharmaceuticals, softgel capsules have emerged as a preferred drug delivery system owing to their numerous advantages over traditional solid dosage forms. Softgels are known for their ability to encapsulate both liquid and semi-solid formulations, which significantly enhances the bioavailability of poorly water-soluble drugs. This has fueled the adoption of these capsules in the pharmaceutical sector, as they enable the formulation of drugs that exhibit improved efficacy and therapeutic outcomes. Furthermore, the ease of swallowing softgel capsules, particularly for pediatric and geriatric patients, has contributed to their growing use in the industry.
Saudi Arabia, like the UAE, has seen a surge in the consumption of softgel supplements. The Saudi population is placing a strong emphasis on health and wellness, driving the demand for dietary and nutraceutical products that are delivered through softgel capsules. This trend is further amplified by a growing middle-class segment with higher disposable income, allowing consumers to invest in their health and well-being through softgel-based supplements.
In Argentina and Chile, the consumption of softgel supplements is on the rise, fueled by a combination of factors. Both countries are experiencing a shift toward healthier lifestyles, with consumers seeking products that enhance their wellness. Softgel capsules are well-suited to meet the dietary and nutritional needs of individuals in these South American nations. These factors collectively drive the preference for softgel-based supplements in this region and, thus, propel the growth of the market.
The Brazil market dominated the LAMEA Softgel Capsules Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $119.6 Million by 2030. The Argentina market is showcasing a CAGR of 8.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.3% during (2023 - 2030).
Based on Type, the market is segmented into Gelatin, and Non-gelatin. Based on Application, the market is segmented into Nutraceuticals & Dietary Supplements, Pharmaceuticals, and Cosmetics. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Supermarkets & Hypermarkets, and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Egypt, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Softgel Capsules Market is Projected to reach USD 6.8 Billion by 2030, at a CAGR of 5.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Gelita AG, Darling Ingredients, Inc., Nitta Gelatin, Inc., SAS Gelatines Weishardt, Lapi Gelatine S.p.a (Lapi Group), Captek Softgel International, Inc., Thermo Fisher Scientific, Inc., EuroCaps (DCC Plc), Lonza Group AG (Capsugel), and Procaps Group.
By Type(Volume, Million Units, USD Billion, 2019-2030)
By Application (Volume, Million Units, USD Billion, 2019-2030)
By Distribution Channel (Volume, Million Units, USD Billion, 2019-2030)
By Country (Volume, Million Units, USD Billion, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
